GlassScriptPhysician profile
Tracy Lynn Schierer
NPI 1275869240
$6,007.32
in general payments reported to CMS, 2019-2025
38 companies · $1,553 in 2025
The $1,553 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $404 · 2022: $644 · 2023: $1,664 · 2024: $1,742 · 2025: $1,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,877 · Travel and Lodging: $970 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,876.55 |
| Travel and Lodging | $970.34 |
| Education | $111.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,732.14 | 2021-2024 | Interstim, Intellis Adaptivestim |
| Sumitomo Pharma America, INC. | $698.49 | 2023-2025 | Gemtesa |
| Janssen Biotech, INC. | $515.59 | 2023-2025 | Erleada, Rybrevant, Carvykti |
| Dendreon Pharmaceuticals LLC | $498.54 | 2023-2025 | Provenge |
| Abbvie INC. | $326.76 | 2021-2025 | |
| Pfizer INC. | $216.22 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $208.53 | 2024-2025 | Adstiladrin |
| Astellas Pharma US INC | $162.66 | 2023-2025 | Xtandi, Myrbetriq, Veozah |
| Progenics Pharmaceuticals, INC. | $162.58 | 2023-2025 | Pylarify |
| Tolmar, INC. | $143.54 | 2023-2025 | Jatenzo |
| Kowa Pharmaceuticals America, INC. | $127.94 | 2023 | Seglentis, Livalo |
| Biohaven Pharmaceutical Holding Company LTD. | $126.31 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.09 | 2024-2025 | |
| Olympus America INC. | $115.39 | 2023-2025 | Itind System, Soltive |
| Amgen INC. | $106.17 | 2021-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Lynn Schierer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.